Powered by
ProMIS Neurosciences appoints Director
Mar 3, 2017 - News Bites Canadian Markets


Corporate Wire Date: 03 March 2017 04:00 EST

ProMIS Neurosciences has appointed Anthony J. Giovinazzo as a Director. The effective date is Thursday, March 02.

Appointments to the Board of ProMIS Neurosciences in the past year:


TORONTO, March 2, 2017 /CNW/ - ProMIS Neurosciences ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative diseases

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox